Log In
BCIQ
Print this Print this
 

Spanidin, gusperimus

Also known as: NKT-01

  Manage Alerts
Collapse Summary General Information
Company Nippon Kayaku Co. Ltd.
DescriptionChemically synthesised selective immunosuppressive agent
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRenal transplant rejection
Indication DetailsImmunosuppressant for treatment of acute and accelerated rejection crisis after renal transplantation
Regulatory Designation
PartnerNordic Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/20/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today